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ABSTRACT
The emergence of medicine resistance strains of influenza 
A viruses to the chemical drogs lead to the development of 
alternative herbal compounds that inhibit the virus replication. 
Therefore, the aim of this research was to investigate in vitro 
anti-influenza A viruses activity, antioxidant potential, total 
phenolic, and flavonoid content of a total of 12 hydro alcoholic 
crude extracts obtained from 8 kinds of medicinal plants. Anti-
influenza A viruses activity of the extracts was investigated by 
the using of MDCK cell line and MTT (3-[4,5-dimethylthiazol–
2-yl]-2,5-diphenyltetrazolium bromide) method. Both 
50% inhibitory concentration (IC50) and 50% cytotoxicity 
concentration (CC50) of the extracts were identified using 
regression analysis. The antioxidant activity, total phenol, and 
flavonoid content of the extracts were determined using 2, 
2-diphenyl-1-picrylhydrazyl (DPPH) assay, Folin-Ciocalteu 
method, and aluminum chloride colorimetric method, 
respectively. The results demonstrated that there was high 
activity against influenza virus for Peganum harmala L., 
Equisetum arvense L., and Punica granatum L, extracts with IC50 
value of 9.1 (CI95%:7.3-11.3), 6.45 (CI95%: 4.5-9.23), and 104.5 
(CI95%: 82.8-131.8), respectively. DPPH radical scavenging 
activity showed that both Equisetum arvense L. and Punica 
granatum L. demonstrated the highest antioxidant activity with 
IC50 value of 6.5, 6.8 and 7.7 μg/mL, respectively. According to 
the results, some of these extracts might be further analyzed to 
develop effective anti-influenza factors.
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1. Introduction
Among different kinds of viruses, one of the most common 
human respiratory tract pathogens that have high level of 
morbidity and death rate is influenza virus [1]. Segmented 
ribonucleic acid genome and animal reservoir cause genetic 
reassortment in the virus. The appearance of new human 
and non-human source of influenza virus with the ability 
to cross-species barriers creates with high rate of antigenic 
drift and shift; also it changes to pathogenic type in their new 
hosts [2, 3].
Currently, in order to treat anti-influenza A virus two main 
groups of medicines including matrix protein (M2), ion-
channel inhibitors (Rimantadine and Amantadine), and 
neuraminidase inhibitors (Zanamivir, Oseltamivir, and 
Peramivir) are confirmed. On the one hand, the lack of an 
effective immunogenic vaccine improved against this virus; 
and on the other, the constant evolvement of influenza A 
virus causes the rapid emergence of resistance to current 
medicines [4, 5]. Therefore, it is essential to make the new 
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and efficient anti-influenza medicines in order to treat 
resistant forms of influenza A virus.
For a long time, plants have been used as remedies and have 
shown the ability to synthesize a wide range of compounds. 
Therefore, in order to identify the probable sources of herbal 
medicines several plants are being gathered and examined 
[6-11]. Besides, different screening experiments have been 
performed on these plants to isolate the agents with antiviral 
activity [12-15]. In some cases of these herbal medicines 
there has been a development into therapeutic agents and 
they have had promising outcomes.
Iran with rich and diverse local health tradition is endowed 
valuable plant genetic source. In order to verify their efficacy 
and safety, more detailed survey and documentation of plants 
used in local health traditions and ethnopharmacological 
evaluation might lead to the development of invaluable 
herbal medicines or isolation of compounds of therapeutic 
value. Therefore, this research was aimed to investigate 12 
species of plants for antiviral activity against influenza A 
virus.
2. Matrials and methods
Plant collection and extraction
Different parts of 12 medicinal plants belonging to 8 different 
families (Table I) were tested for their antiviral activity. The 
selected plants were provided from market of medicinal 
plants from Shahrekord, Iran (southwest of Iran) and were 
identified by the Dr. Lorigooini according to the Flora of 
Iran. Voucher specimens of the plants were deposited in the 
herbarium of the Medical Plants Research Center, Shahrekord 
University of Medical Sciences, Iran (Table 1).
Plants were dried, powdered, and extracted using maceration 
method. The plant material was dissolved in 70% ethyl 
alcohol and kept at room temperature (RT) for 96 h. After 
that, the mixture was filtered and concentrated under nearly 
vacuum pressure at 40°C by using rotary evaporator. In order 
to further use, the extracts were kept in sterile bottles and 
under refrigerated conditions. In the following, the extracts 
were suspended at 37°C in dimethylsulphoxide (DMSO) 
to give a stock solution of 10mg/mL, dissolved in culture 
medium, filtered and stored (4°C) until used. The little 
percentage of DMSO present in the wells (maximal 0.2%) has 
no effect on the results of the experiments [16].
Determination of the free-radical scavenging activity
In 2,2 diphenyl-1-picrylhydrazyl (DPPH) method described 
by Moon and Terao with some modifications, the free–
radical scavenging activity was measured [17]. Briefly, 
different amounts of the extracts and methanol were added 
to a solution of 0.3 mg/mL methanolic solution of DPPH in 
order to make a total volume of 3.0 mL. After incubation 
for 15 min at RT, the absorbance was measured at 517 nm 
using UV–VIS pectrophotometer (UNICO 2100: USA). 
Table 1. Ethnobotanical data of selected medicinal plants
NO Family Plant name Part used Local name Common name Voucher
1 Apiaceae Ferula gummosa Boiss gum Barigeh Galbanum MPSKUMS-650
2 Apiaceae Ferula assa-foetida L Leaves Anghozeh Asafoetida MPSKUMS-470
3 Apiaceae Prangos ferulacea (L.) gum Jashir Ribbed Cachrys MPSKUMS-320
4 Berberidaceae Berberis integerrima Bunge root Zereshkekoohi Barberry MPSKUMS-512
5 Equisetaceae Equisetum arvense L. Aerial parts Domeasb Horsetail MPSKUMS-516
6 Lamiaceae Ziziphora clinopodioides Lam. Aerial parts Kakooti - MPSKUMS-253
7 Lamiaceae Thymus daenensis Celak. Aerial parts Avishandenaei thyme MPSKUMS-248
8 Lamiaceae Hyssopus officinalis L. flowers Zofa hyssop MPSKUMS-177
9 Lythraceae Punica granatum L. Peel fruits Anar Pomegranate MPSKUMS-316
10 Pteridaceae Adiantum capillus-veneris L. Leaves Parsiyavash maidenhair MPSKUMS-131
11 Rosaceae Crataegus azarolus L. Leaves Zalzalak Hawthorn MPSKUMS-499
12 Zygophyllaceae Peganum harmala L Seed Espand Syrian rue MPSKUMS-188
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High absorbance of the reaction mixture indicated low free 
radical scavenging activity. Butylated hydroxytoluene (BHT) 
was used as reference standard. Inhibition of free radical by 
DPPH was calculated as follows: Antiradical activity (%) = 
(Acontrol – Asample)/Acontrol×100. The IC50 value was 
defined as the amount of antioxidant necessary to reduce the 
initial DPPH concentration by 50%; and was calculated based 
on linear regression of plots of the percentage antiradical 
activity against the concentration of the tested compounds 
[18]. The experiment was performed in triplicate and the 
results had average values.
Determination of total phenolic content
In each plant extract, the total phenolic content was 
determined using Folin-Ciocalteu method with some 
modifications made by Asadi-Samani and coworkers [19]. 
Briefly, 0.1 mL of the diluted sample was added to 0.5 mL 
of 10% (v/v) Folin–Ciocalteu reagent and kept at room 
temperature (RT) for 3-8 min. Subsequently, 0.4 mL of 7.5% 
(w/v) sodium carbonate solution was added to the mixture. 
After being kept in total darkness for 30 min., the absorbance 
of the reaction mixture was measured at 765 nm using a 
UV–VIS spectrophotometer (UNICO 2100: USA). Then, 
amounts of total phenolic were calculated by the application 
of gallic acid calibration curve. The results were expressed as 
gallic acid equivalents (GAE) g/g of dry plant matter.
Determination of total flavonoid content
With the same previously mentioned method, the total 
flavonoid content of each plant extract was measured 
[20]. Independently, 0.5 mL of diluted plant material was 
mixed with 1.5 mL of methanol, 0.1 mL of 10% (w/v) 
aluminum chloride, 0.1 mL of 1M potassium acetate, and 
2.8 mL of distilled water. Based on the incubation at room 
temperature (RT) for 40 min, the absorbance of the reaction 
mixture was read at 415 nm by the application of a UV–VIS 
spectrophotometer (UNICO 2100: USA). The results were 
presented in mg of Rutin equivalents of dry plant matter in 
comparison with the standard curve; which was made in the 
same condition.
Cell and Virus
Madin Darby Canine Kidney (MDCK) cells were grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco, USA), 
supplemented with 10% fetal bovine serum (FBS; Gibco, 
USA) and 1% Pen/Strep (Gibco, USA) at 37°C in a 5% CO2 
atmosphere and humidified incubator.
MDCK cell line and Influenza A virus (A/
Iran/12/2014(H1N1)) was obtained from Influenza Unit, 
Pasteur Institute of Iran. Before the viral infection, MDCK 
cells were washed twice with phosphate buffered saline (PBS) 
and cultured in virus growth medium containing DMEM 
with penicillin/streptomycin, 2μg/mL trypsin TPCK (Sigma-
Aldrich, USA), and 0.3% bovine serum albumin (BSA, 
Gibco, USA).
Virus titration
A standard 50% tissue culture infectious doses (TCID50) 
method was applied for virus titration [21]. When, 90% 
confluent MDCK cells were prepared in 96 well plates, the 
cell culture medium was aspirated and washed twice with 
phosphate-buffered saline (PBS). Then, 200μL of a series of 
10-fold dilutions of virus in virus growth medium containing 
DMEM with 0.5μg/mL trypsin TPCK was added into the 
wells and left to incubate for 2 days. Consequently, 50μL of 
culture medium were taken from each well and transferred to 
a U-bottomed 96-well plate for hemagglutination experiment 
[22]. TCID50 which was calculated based on the method of 
Reed and Muench [23].
Screening of antiviral activity
The antiviral activity of each plant extract was screened in 
96-well culture plates by measuring the reduction of the 
viral cytopathic effect (CPE) [24]. Briefly, confluent MDCK 
cell monolayers were infected with 100µL (100TCID50) of 
virus suspension and incubated at 37oC for about one hour 
to allow virus adsorption and then the virus was removed 
and the cells were treated with 25, 50 and 100 μg/mL of 
each extracts [24] supplemented with 2 μg/mL TPCK and 
0.3% BSA (200μL/well). The plates were incubated at 37°C 
in a humidified CO2 atmosphere until 90% of viral CPE 
in the control virus was reached. The reduction of viral 
CPE was determined by measuring cell viability by the 
tetrazolium salt MTT [3-(4,5-dimethylthiazol-2-ol)-2,5-
diphenyltetrazoliumbromide), (Sigma, USA)] colorimetric 
assay.
Results of the screening were expressed as positive (+), 
reduction of viral CPE was higher than 50% at all three 
concentrations tested, negative (−) without protection at 
all three concentrations tested, (++/−) reduction of viral 
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CPE was higher than 50% at 100 and 50μg/mL, and +/−− 
reduction of viral CPE was higher than 50% only at 100μg/
mL [24].
Cytotoxicity Experiment
The cytotoxic effect (CPE) of the positive extracts was 
determined before the investigation of anti-influenza A virus 
activity. MDCK cells were seeded onto 96-well plates with a 
concentration of 15000 cells/well with final volume of 100 µL 
per well. After incubation at 37°C with 5% CO2 for 24 h, while 
the cell monolayer was confluent, the cell culture medium of 
cells aspirated and washed with PBS. Cells were incubated 
with 100µL/well of various concentrations of three positive 
plant extract (Punica granatum L., Equisetum arvense L. and 
Peganum harmala L.) (in DMEM), and incubated at 37°C 
with 5% CO2 for further 3 days. Cell viability was investigated 
by the ability of the cells to cleave the tetrazolium salt MTT, 
by the mitochondrial enzyme succinate dehydrogenase that 
develops a formazan blue color product, and also by the 
procedure was followed as described earlier [25]. In sum, the 
supernatants were removed from the wells in this phase and 
50 μL of an MTT (Sigma, USA) solution (1mg/mL in PBS) 
was added to each well. The plates were incubated for 4 h at 
37°C, and 100 μL of DMSO (sigma, USA) was added to the 
wells to dissolve the MTT crystals. The plates were located 
on a shaker for 15 min and the absorbance were read on an 
enzyme-linked immunosorbent experiment (ELISA) reader 
(STATA FAX 2100, USA) at 492 nm. Data of the study were 
calculated as the percentage of toxicity by the application of 
the following formula: toxicity (%)=[100– (At/As) ×100] %, 
where At and As refer to the absorbance of the test substance 
and the solvent control, respectively [16]. Therefore, the 
50% cytotoxic concentration (CC50) was explained as the 
cytotoxic concentration of the crude extracts by regression 
Pribit model.
Antiviral Experiment
In positive extracts the antiviral activity was evaluated by 
inhibitory activity experiment using MTT method that 
described previously [16]. To test the ability of extracts to 
inhibit CPE of influenza virus in tissue culture, non-cytotoxic 
concentrations of each extracts (below the CC50 value) were 
applied. Confluent MDCK cells monolayer were infected 
with 100µL (100TCID50) virus suspension and incubated at 
37oC for about one hour to allow virus adsorption. Then, the 
virus was removed and the cells were treated with serial two 
fold dilutions from nontoxic concentration of three positive 
plants extract (Punica granatum L., Equisetum arvense L. and 
Peganum harmala L.) in DMEM supplemented with 2 μg/
mL TPCK, and 0.3% BSA (200μl/well). Medium with 0.1% 
DMSO and oseltamivir (Sigma, USA) were used as negative 
and positive controls, respectively. The plates were incubated 
at 37°C in a humidified CO2 atmosphere for 48 h. Also, cell 
viability was determined by the application of previously 
described MTT experiment; and the percentage of protection 
were calculated as the percentage of inhibition according 
to the following formula: Antiviral activity (%)=(Atv–
Acv)/(Acd–Acv) ×100%, where Atv, Acv, and Acd are the 
absorbance of the test compounds in virus infected cells, the 
absorbance of the virus control, and the absorbance of the 
cell control, respectively[16]. The procedure was performed 
in triplicate and the 50% inhibitory concentration (IC50) 
was determined by regression Pribit model. As a marker of 
antiviral activity, selectivity index was determined as the 
ratio of CC50 to IC50.
Statistical analysis
All the experiments were carried out in triplicate. The 
spearman’s correlation test was used to determine whether 
the total phenolic contents and the free radical scavenging 
property were correlated or not. The IC50 and CC50 values 
were calculated by the application of dose-response analyses 
and related models with probit procedure using SPSS 
software.
3. Results
DPPH radical scavenging activity, Total phenolic and 
flavonoid compounds
Different parts of 12 medicinal plants belonging to 8 different 
families (Table I) were used traditionally for treatment of 
diseases and were tested for their antiviral activity. Their 
DPPH radical scavenging activity, total phenolic, and 
flavonoid contents were measured. DPPH radical scavenging 
activity demonstrated that the Equisetum arvense L. and 
Punica granatum L. has shown the highest IC50 value (6.5, 6.8 
and 7.7 μg/mL, respectively) in comparison with the other 
extracts under the investigation. The results are presented in 
relation to the butylated hydroxytoluene (BHT), a reference 
standard that has IC50 of 25.41±1.89 μg/mL. Besides, results 
demonstrated that among 12 medicinal plant extract, the 
Punica granatum L. (282.9), Equisetum arvense L. (262.1), 
and Crataegus azarolus L. (214.2) had the highest amount of 
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total phenolic compounds. There was negatively significant 
correlation between total phenolic content and IC50 of 
DPPH scavenging activity values (r=-0.8472, p<0.001). The 
highest amount of flavonoid (57.2) compound was observed 
in Punica granatum L. (57.6) and Adiantum capillus-veneris 
L. (Table2).
Screening of antiviral activity
Three out of 12 tested plants extract were reported to have 
antiviral activity at a nontoxic concentration to the used cell 
line against influenza virus (MDCK) (Table 2).
Cytotoxicity and Antiviral Experiment
In the present study, in vitro anti influenza activity of 
hydroalcoholic extracts were evaluated using MDCK cell 
line. According to MTT analysis and probit analysis, the 
CC50 value of Punica granatum L., Equisetum arvense L. and 
Peganum harmala L. crud extracts on MDCK cells were 
55.66 (48.4-64), 639.3 (592-689.9), 122.9 (107.8-140) μg/
mL, respectively. The analysis demonstrated that the extract 
concentration was significantly related to the cell death 
(P<0.01, Figure 1).
The antiviral activity of the most promising extracts 
detected during the screening procedure was more 
evaluated in detail by the application of MTT method. 
MDCK cells were inoculated with 100 TCID50 (100 µL/well) 
of influenza virus for 1h and were treated with various doses 
of Punica granatum L., Equisetum arvense L. , and Peganum 
harmala L. crude extracts. Findings of this study showed 
that the more extract concentration, the more cytopathic 
effect (CPE) inhibition (P<0.05, Figure 1). According to 
Probit analysis, the extracts of Peganum harmala L., Punica 
granatum L., and Equisetum arvense L. had high activity 
against influenza virus with IC50 values of 9.1 (CI95%:7.3-
11.3), 6.45 (CI95%: 4.5-9.23), and 104.5 (CI95%: 82.8-
131.8), respectively (Table 3). Most of these extracts had 
partial activity at the applied low concentration. The results 
demonstrated that Punica granatum L., Equisetum arvense 
L., and Peganum harmala L. exhibited the highest SI values 
(8.63, 6.12 and 13.5, respectively) against Influenza virus 
(Table 3).
Table 2. DPPH-radical scavenging activity (IC50), total phenolics and flavonoid contents and Screening of antiviral activity 
against influenza A virus of plants extract
NO Plant name
DPPH-radical
scavenging
activity
IC50 (μg/ml )
Total phenolics
(mg GAE/g)
Flavonoid content
(mgRUT/g)
Anti influenza virus 
activity
1 Peganum harmala L 125.8 111.16 46.2 +
2 Ferula gummosa Boiss >1000 33.26 - -
3 Ferula assa-foetida L 396.6 110.4 51.2 -
4 Prangos ferulacea (L.) >1000 43.17 - -
5 Equisetum arvense L. 22.7 136.2 25.25 +/--
6 Punica granatum L. 10.33 174.9 60.6 +
7 Crataegus azarolus L. 231 171.38 69.9 -
8 Berberis integerrima Bunge 163.2 100.42 25.21 -
9 Ziziphora clinopodioides Lam. 31.8 165.88 109.2 -
10 Thymus daenensis Celak. 51.9 114.83 92.45 -
11 Adiantum capillus-veneris L. 235.9 110.3 51.2 -
12 Hyssopus officinalis L. 522.2 58.77 27.14 -
The antiviral activity was tested by the reduction of viral cytopathic effect (CPE) assays.
(+) positive: reduction of viral CPE higher than 50% at all three concentrations tested.
(++/−) reduction of viral CPE higher than 50% at 100 and 50 μg/mL
(+/−−) positive/negative: reduction of viral CPE only at 100 μg/mL.
(−) negative: without protection at 25, 50 and at 100 μg/mL.
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Table 3. Assessment of cytotoxicity and Anti influenza virus activity of selected plant extracts by MTT assay in MDCK cell line
Plant name CC50
aμg/ml (CI95%) IC50bμg/ml (CI95%) SIc
Punica granatum L. 55.66 (48.4-64) 6.45 (4.5-9.23) 8.63
Equisetum arvense L. 639.3 (592-689.9) 104.5 (82.8-131.8) 6.12
Peganum harmala L. 122.9 (107.8-140) 9.1 (7.3-11.3) 13.5
Oseltamivir(µmol)* 539.4 (378.9-768.5) 0.873 (0.55-1.37) 617.8
aCC50: 50%cytotoxic concentration, bIC50: 50%inhibitory concentration; cSI: Selectivity index, is the ratio of CC50 to IC50; CI95%: 95% Confi-
dence Interval; *Oseltamivir was used as positive controls.
Table 3. Assessment of cytotoxicity a d Anti influenza virus activity of selected pl nt extracts 
by MTT assay in MDCK cell line 
Plant name CC50aμg/ml (CI95%) IC50bμg/ml (CI95%) SIc 
Punica granatum L. 55.66 (48.4-64) 6.45 (4.5-9.23) 8.63 
Equisetum arvense L. 639.3 (592-689.9) 104.5 (82.8-131.8) 6.12 
Peganum harmala L. 122.9 (107.8-140) 9.1 (7.3-11.3) 13.5 
Oseltamivir(µmol)* 539.4 (378.9-768.5) 0.873 (0.55-1.37) 617.8 
aCC50: 50%cytotoxic concentration, bIC50: 50%inhibitory concentration; cSI: Selectivity index, is the ratio 
of CC50 to IC50; CI95%: 95% Confidence Interval; *Oseltamivir was used as positive controls. 
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Figure 1. Anti influenza virus activity and cytotoxicity of Punica granatum L., Equisetum arvense L. and 
Peganum harmala L. extracts on MDCK cell lines. Confluent MDCK cells without virus or after influenza A 
virus infection were exposed to different concentrations of the extract for 48h. Cell viability was measured with 
MTT assay. Results are means ± SD from three experiments. 
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Figure 1. Anti influenza virus activity and cytotoxicity of Punica granatum L., Equisetum arvense L. and Peganum harmala 
L. extracts on MDCK cell lines. Confluent MDCK cells without virus or after influenza A virus infection were exposed to 
different co centrations of the extract for 48h. Cell viability was measured with MTT assay. Resul s are mean  ± SD from three 
experiments.
DPPH radical scavenging activity showed that the IC50 of 
Equisetum arvense L. and Punica granatum L. extracts (6.5, 
6.8 and 7.7μg/mL, respectively) was less than the other plant 
extracts under study. These results showed that the radical 
scavenging activity of these plants extracts were higher than 
BHT. The antioxidant potential and phenolic diversity in 
many plants have been previously reported [30, 31]. In present 
4. Discussion
Initial screening of plants typically begins by using crude 
aqueous or alcohol extraction in order to explore their active 
natural products and then will be followed by various organic 
extraction methods [26-29]. In this study, we investigated 
12 plant extracts for their anti-influenza virus activity, 
antioxidant potential, and total phenolic compounds.
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study, the amount of phenolic compounds was expressed as 
gallic acid equivalent. Our results showed that among the 
12 medicinal plants extract, the Punica granatum L. (282.9), 
Equisetum arvense L. (262.1), and Crataegus azarolus L. 
(214.2) had the highest amount of total phenolic compounds. 
There was a negatively significant correlation between 
phenolic content and IC50 values (r=-0.8472, p<0.001). 
Phenolic compounds by donation of one H+ cause scavenging 
free radicals and inhibition of macromolecules damage. In 
other words, in these extracts, phenolic compounds may be 
responsible for a part of radical scavenging activity. In other 
researches, a moderate correlation was found between DPPH 
radical scavenging and phenolic content in plant extract [32, 
33].
According to Probit analysis, crude extracts of Peganum 
harmala L., Punica granatum L., and Equisetum arvense L. 
had high activity against influenza virus with IC50 values of 9.1 
(CI95%:7.3-11.3), 6.45 (CI95%: 4.5-9.23), and 104.5 (CI95%: 
82.8-131.8) respectively. As an IC50 value of a characteristic 
herbal extract against infectious diseases is less than 100 μg/
mL [33], these extracts should have strong antiviral activity 
against influenza virus.
The antiviral activity of pomegranate extract may be 
associated with the presence of hydrolysable tannins and 
polyphenols, specifically punicalagin and gallagic acid [34].
Peganum harmala L. with some alkaloids compounds has 
been considered from long time ago as a herbal medicine. 
The pharmacochemical studies compounds of this herb 
include several alkaloids, β-carbolines (such as harmine, 
harmaline, harman and harmalol), and the quinazoline 
derivatives of vasicine and vasicinone [35]. It has been 
reported that two alkaloid compounds of the β-carbolines 
and the quinazoline have anti-influenza A virus activity [36-
38]. Therefore, the anti-influenza A virus activity of Peganum 
harmala L. extract used in this study could be attributed to its 
alkaloid components.
The Punica granatum L.peel is considered as an agro-waste but 
it can be a potential source of various phenolic and flavonoid 
compounds which shows antibacterial, antiviral, antioxidant, 
anti-inflammatory and antineoplastic bioactivities [39]. 
The anti-influenza A virus activity of this extract could be 
attributed to its phenolic compounds. The anti-influenza A 
virus activities of some extracts have been attributed to their 
phenolic and flavonoid compounds. Therefore, other plants 
having these compounds [40-44] may also have antiviral 
activities which worth examining.
5. Conclusion
Equisetum arvense L. and Punica granatum L. extracts were 
rich in total phenolic compounds and exhibited antioxidant 
activity higher than the other plants tested. Also, there was 
a significant correlation between phenolic content and 
antioxidant activity. Since Equisetum arvense L., Punica 
granatum and Peganium harmala L. extracts have inhibited 
influenza virus replication, therefore further research is 
needed to elucidate the active constituents of these extracts 
for discovering of the novel anti-influenza activity agents.
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